Hercessi
Trastuzumab-strf · Accord BioPharma Inc.
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Hercessi ingredients
| Active ingredient | Strength |
|---|---|
| Trastuzumab-Strf | 150 mg/7.4mL, 420 mg/20mL |
What Hercessi is used for
Hercessi is a cancer medicine (her2/neu receptor antagonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Hercessi
- Generic name
- Trastuzumab-strf
- Made by
- Accord BioPharma Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution, Kit
- Given
- Intravenous
- Drug class
- HER2/neu Receptor Antagonist
- FDA approval
- Biologic licence (BLA) BLA761346
- On the US market since
- 2025
Official information
- MedlinePlus drug information (search for Trastuzumab-strf)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Hercessi?
Hercessi (Trastuzumab-strf) is a cancer medicine made by Accord BioPharma Inc., approved by the US FDA.
What are the ingredients of Hercessi?
Hercessi contains Trastuzumab-Strf (150 mg/7.4mL, 420 mg/20mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA